According to Shinpoong Pharm's latest financial reports the company's current EPS (TTM) is -โน52.71. In 2022 the company made an earnings per share (EPS) of -โน45.56 a decrease over its 2021 EPS that were of -โน16.13.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน50.72 | 11.33% |
2022 | -โน45.56 | 182.43% |
2021 | -โน16.13 | -326.47% |
2020 | โน7.12 | -8.85% |
2019 | โน7.81 | 75.6% |
2018 | โน4.45 | 269.67% |
2017 | โน1.20 | -103.94% |
2016 | -โน30.57 | -1436.05% |
2015 | โน2.29 | -71.86% |
2014 | โน8.13 | -29.56% |
2013 | โน11.54 | -24.55% |
2012 | โน15.30 | -68.07% |
2011 | โน47.92 | 22.65% |
2010 | โน39.07 | 11.53% |
2009 | โน35.03 | 55.55% |
2008 | โน22.52 | 19.44% |
2007 | โน18.85 |